ALBANO, Emanuele
 Distribuzione geografica
Continente #
NA - Nord America 9.457
EU - Europa 8.902
AS - Asia 4.859
SA - Sud America 763
Continente sconosciuto - Info sul continente non disponibili 128
AF - Africa 125
OC - Oceania 5
Totale 24.239
Nazione #
US - Stati Uniti d'America 9.292
RU - Federazione Russa 2.163
IE - Irlanda 1.977
SG - Singapore 1.547
CN - Cina 1.146
DE - Germania 1.145
SE - Svezia 1.124
UA - Ucraina 862
HK - Hong Kong 843
VN - Vietnam 618
BR - Brasile 600
FI - Finlandia 540
IT - Italia 410
FR - Francia 323
KR - Corea 189
GB - Regno Unito 166
IN - India 149
CA - Canada 82
AR - Argentina 76
TR - Turchia 59
BD - Bangladesh 51
ID - Indonesia 50
BE - Belgio 48
MX - Messico 48
IR - Iran 38
PL - Polonia 37
IQ - Iraq 35
ZA - Sudafrica 33
BJ - Benin 31
EC - Ecuador 31
EU - Europa 27
JP - Giappone 26
ES - Italia 24
NL - Olanda 22
DZ - Algeria 13
PK - Pakistan 13
PY - Paraguay 13
AT - Austria 12
AE - Emirati Arabi Uniti 11
CO - Colombia 11
KE - Kenya 11
PH - Filippine 11
SA - Arabia Saudita 11
CL - Cile 10
CZ - Repubblica Ceca 10
VE - Venezuela 10
LT - Lituania 9
JO - Giordania 8
TH - Thailandia 8
EG - Egitto 7
UZ - Uzbekistan 7
JM - Giamaica 6
CH - Svizzera 5
CI - Costa d'Avorio 5
MA - Marocco 5
MD - Moldavia 5
NP - Nepal 5
RO - Romania 5
RS - Serbia 5
TN - Tunisia 5
UY - Uruguay 5
AZ - Azerbaigian 4
CR - Costa Rica 4
HN - Honduras 4
KZ - Kazakistan 4
MY - Malesia 4
NG - Nigeria 4
PE - Perù 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
AO - Angola 3
AU - Australia 3
GA - Gabon 3
IL - Israele 3
KG - Kirghizistan 3
NI - Nicaragua 3
PA - Panama 3
PT - Portogallo 3
AL - Albania 2
BO - Bolivia 2
CY - Cipro 2
ET - Etiopia 2
GT - Guatemala 2
KW - Kuwait 2
MN - Mongolia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
CG - Congo 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GD - Grenada 1
GY - Guiana 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
Totale 24.128
Città #
Dublin 1.968
Jacksonville 1.501
San Jose 1.005
Hong Kong 838
Dearborn 748
Singapore 646
Chandler 580
Council Bluffs 523
Ashburn 472
Beijing 388
Wilmington 364
Moscow 288
Lawrence 262
Princeton 262
Lauterbourg 231
San Mateo 225
Los Angeles 217
Ho Chi Minh City 211
Ann Arbor 190
Seoul 186
Andover 182
Columbus 147
Buffalo 145
Hanoi 106
Munich 102
New York 96
Santa Clara 95
Philadelphia 79
Boardman 78
São Paulo 63
Houston 62
Dallas 61
Woodbridge 61
Piemonte 58
Kocaeli 47
Novara 46
Brussels 44
Hefei 43
Helsinki 43
Kunming 39
Norwalk 39
Orem 39
Monmouth Junction 36
Nanjing 35
Grafing 34
Milan 33
Brooklyn 31
Cotonou 31
Denver 30
Dong Ket 30
Redondo Beach 30
Turin 30
Guangzhou 29
Warsaw 29
Jakarta 28
Tianjin 27
Bremen 26
Toronto 26
Fairfield 25
Da Nang 24
Haiphong 24
Hangzhou 24
Nanchang 24
Rome 24
Atlanta 22
Tokyo 22
Düsseldorf 21
Leawood 21
Chennai 20
Frankfurt am Main 20
Stockholm 20
Strasbourg 20
London 19
Jinan 18
Johannesburg 18
Nuremberg 18
Phoenix 18
Mumbai 17
Rio de Janeiro 17
Ardabil 16
Poplar 16
Seattle 16
Shanghai 16
Augusta 15
Boston 15
Montreal 15
Zanjan 15
Can Tho 14
Manchester 14
Mexico City 14
San Francisco 14
Biên Hòa 13
Chicago 13
Curitiba 13
Shenzhen 13
St Louis 13
Hải Dương 12
Amsterdam 11
Fuzhou 11
Guayaquil 11
Totale 13.991
Nome #
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 193
Inducible T-Cell Costimulator Mediates Lymphocyte/Macrophage Interactions During Liver Repair 176
B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD) 165
Annexin A1 treatment prevents the evolution to fibrosis of experimental nonalcoholic steatohepatitis 156
CX3CR1 Mediates the Development of Monocyte-Derived Dendritic Cells during Hepatic Inflammation 149
Bias in macrophage activation pattern influences non-alcoholic steatohepatitis (NASH) in mice 147
CX3CR1 modulates the anti-inflammatory activity of hepatic dendritic cells in response to acute liver injury 147
Vegetal oil-based ketogenic diet improves inflammation and fibrosis in experimental metabolic dysfunction-associated steatohepatitis 146
CX3CR1-expressing inflammatory dendritic cells contribute to the progression of steatohepatitis 146
A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16 144
Fat-laden macrophages modulate lobular inflammation in nonalcoholic steatohepatitis (NASH) 142
Adaptive immunity: an emerging player in the progression of NAFLD 140
A polymorphism in CTLA-4 is associated with the presence of anti-CYP2E1 antibody titres in patients with alcoholic liver disease 139
Toxicity of 1,2-dibromoethane in isolated hepatocytes: role of lipid peroxidation. 137
PREVALENCE OF AUTO-ANTIBODIES AGAINST CYTOCHROME P4502E1 IN ALCOHOLIC LIVER DISEASE 135
A case-control histological study on the effects of phlebotomy in patients with chronic hepatitis C 135
Adenosine A2a receptor stimulation prevents hepatocyte lipotoxicity and nonalcoholic steatohepatitis (NASH) in rats. 135
Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH 133
Autoimmune and HCV-related LKM1 reacts with CYP2D6 on the plasma membrane of isolated rat hepatocytes 131
ACTIVATION OF CHLOROFORM AND RELATED TRIHALOMETHANES TO FREE-RADICAL INTERMEDIATES IN ISOLATED HEPATOCYTES AND IN THE RAT INVIVO AS DETECTED BY THE ESR-SPIN TRAPPING TECHNIQUE 128
Pharmacological postconditioning protects against hepatic ischemia/reperfusion injury 125
Valine-alanine manganese superoxide dismutase polymorphism is not associated with alcohol-induced oxidative stress or fibrosis 123
Adenosine A2a receptor stimulation Reduces inflammatory Th cells subsets in steatotic mice liver and prevents progression to NASH 123
Alteration of Na+ homeostasis as a critical step in the development of irreversible hepatocyte injury after adenosine triphosphate depletion. 122
SerpinB3 as a Pro-Inflammatory Mediator in the Progression of Experimental Non-Alcoholic Fatty Liver Disease 121
Apoptotic cells are the target of anti-phospholipid antibodies associated with alcoholic liver disease 121
Valine-alanine manganese superoxide dismutase polymorphism is not associated with alcohol-induced oxidative stress or liver fibrosis.Lipid 120
Adenosine A2a receptor-mediated, normoxic induction of HIF-1 through PKC and PI-3K-dependent pathways in macrophages 120
Alterations of Na+ homeostasis in hepatocyte reoxygenation injury 119
ALTERATIONS OF HEPATOCYTE CA2+ HOMEOSTASIS BY TRIETHYLATED LEAD (ET(3)PB(+)) - ARE THEY CORRELATED WITH CYTOTOXICITY 119
Apoptotic cells are the targets of anti-phospholipid antibodies associated with alcoholic liver disease 118
Malondialdehyde-Acetaldehyde (MAA) adducts trigger immune reactions in patients with alcoholic liver disease 117
CYP2E1 autoantibodies in liver diseases 117
The role of immune mechanisms in alcoholic and nonalcoholic steatohepatitis: A 2015 update 117
Ischemic preconditioning reduces Na+ accumulation and hepatocyte death in isolated rat hepatocytes exposed to hypoxia 116
4-hydroxynonenal triggers Ca2+ influx in isolated rat hepatocytes 116
Antiphospholipid antibodies associated with alcoholic liver disease specifically recognise oxidised phospholipids 116
LIPID-PEROXIDATION IN THE PATHOGENESIS OF HEPATOCYTE DEATH 114
Lipid peroxidation promotes antibody formation in patients with alcoholic liver disease 114
Anti-CYP2E1 auto-antibodies in alcoholic liver disease 114
Atrial natriuretic peptide prevents hypoxia-induced Na plus overload and hepatocellular injury by activating p38 MAP kinase 114
Is there a role for adaptive immunity in nonalcoholic steatohepatitis? 114
Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice. 114
Role of phosphatidylinositol 3-kinase in the development of hepatocyte preconditioning 113
Adenosine-dependent activation of hypoxia-inducible factor-1 induces late preconditioning in liver cells 112
B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD) 111
Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunction-associated steatohepatitis 111
Heterozygous β-globin gene mutations as a risk factor for iron accumulation and liver fibrosis in chronic hepatitis C 111
Oxidative stress in alcoholic liver disease 111
Notch signaling and progenitor/ductular reaction in steatohepatitis. 111
Hypoxia-inducible factor 2α drives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine rich glycoprotein 111
Effects of carbon tetrachloride on isolated rat hepatocytes: inhibition of protein and lipoprotein secretion. 110
Antibodies against advanced glycation end product Nepsilon-(carboxymethyl)lysine in healthy controls and diabetic patients 109
Alcohol, oxidative stress and free radical damage 108
EFFECT OF SPIN TRAPS IN ISOLATED RAT HEPATOCYTES AND LIVER-MICROSOMES 108
Endotoxinemia contributes to steatosis, insulin resistance and atherosclerosis in chronic hepatitis C: the role of pro-inflammatory cytokines and oxidative stress 108
Radiolysis of tetrachloro methane. 107
EFFECT OF ETHANOL ON CYTOCHROME-P450-2E1 (CYP2E1), LIPID-PEROXIDATION, AND SERUM-PROTEIN ADDUCT FORMATION IN RELATION TO LIVER PATHOLOGY PATHOGENESIS 107
Role of p38 MAP kinase in glycine-induced hepatocyte resistance to hypoxic injury 107
Studies on lipid peroxidation using whole liver cells: influence of damaged cells on the prooxidant effect of ADP-Fe3+ and CC14. 106
ROLE OF CARBONIC ANHYDRASE EXPRESSION IN HEPATOCYTE PROTECTION BY LATE PRECONDITIONING 106
MECHANISMS OF N-ACETYL-P-BENZOQUINONE IMINE CYTO-TOXICITY 105
Anti-oxidised-phospholipid antibodies do not correlate with specific anti-phospholipid syndrome classes, but with disease duration. 105
Hepatocyte-Specific Deletion of HIF2α Prevents NASH-Related Liver Carcinogenesis by Decreasing Cancer Cell Proliferation 105
ETHANOL FREE RADICAL AND LIVER DISEASE 104
Ethanol potentiates hypoxic liver injury: role of hepatocyte Na(+) overload 103
Free radical intermediates under hypoxic conditions in the metabolism of halogeneted carcinogens. 103
Genetic polymorphism of human CYP2E1: characterization of two variant alleles. 102
STRESS OSSIDATIVO ALCOL – INDOTTO IN PAZIENTI AFFETTI DA EPATITE CRONICA C 102
Role of HIF-1 and carbonic anhydrase IX in the induction of the late protective effects of hepatocyte preconditioning 102
Increased 4-hydroxynonenal protein adducts in male GSTA4-4/PPAR-α double knockout mice enhance injury during early stages of alcoholic liver disease 102
Possible role of ethanol-derived free radicals in the pathogenesis of alcohol-induced liver damage.” 101
Spin trapping studies on the free radical products formed by metabolic activa¬tion of carbon tetrachloride in rat liver microsomal fractions, isolated hepatocytes and in vivo in the rat. 101
Cytochrome P4502E1 hydroxyethyl radical adducts as the major antigen in autoantibody formation among alcoholics 101
Alterations of cell volume regulation in the development of hepatocyte necrosis 100
Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis. 100
The metabolism of halothane by hepatocytes: a comparaison between free radical spin trapping and lipid peroxidation in relation to cell damage. 99
Alcoholic liver disease in rat fed ethanol as part of oral or intragastric low-carbohydrate liquid diet 99
CONVEX WELLS 99
Detection of auto-antibodies against cytochrome P4502E1 (CYP2E1) in chronic hepatitis C 99
Alcohol metabolism: role in toxicity and carcinogenesis 99
Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis. 99
EVIDENCE FOR A SODIUM-DEPENDENT CALCIUM INFLUX IN ISOLATED RAT HEPATOCYTES UNDERGOING ATP DEPLETION 99
FREE-RADICAL METABOLISM OF CARBON-TETRACHLORIDE IN RAT-LIVER MITOCHONDRIA - A STUDY OF THE MECHANISM OF ACTIVATION 98
Beta-alanine protection against hypoxic liver injury in the rat 98
Oncostatin M, A Profibrogenic Mediator Overexpressed in Non-Alcoholic Fatty Liver Disease, Stimulates Migration of Hepatic Myofibroblasts 98
Histidine-rich glycoprotein in metabolic dysfunction-associated steatohepatitis-related disease progression and liver carcinogenesis 97
Evidence for a possible role of lipid peroxidation in experimental liver fibrosis 97
Phlebotomy improves histology in chronic hepatitis C males with mild iron overload 97
Antibodies against oxidized phospholipids in laboratory tests exploring lupus anti-coagulant activity 97
Free radical mechanisms in alcohol-mediated liver injury 96
Enzymatic impairment induced by biological aldehydes in intact rat liver cells. 96
Free radicals and alcohol-induced liver injury 96
Anti-phospholipid antibodies associated with alcoholic liver disease target oxidized phosphatidylserine on apoptotic cell plasma membranes 96
ETHANOL-DERIVED IMMUNOREACTIVE SPECIES FORMED BY FREE-RADICAL MECHANISMS 95
Role of phosphatidylinositol-3-kinase in the signaling of hepatic ischemic preconditioning. 95
Alcohol-induced hepatic injury 95
DOWN REGULATION OF DIACYLGLYCEROL KINASE 0 ACTIVITY MEDIATES THE CYTOPROTECTIVE EFFECT OF HEPATIC PRECONDITIONING 95
Combination of oxidative stress and steatosis is a risk factor for fibrosis in alcohol-drinking patients with chronic hepatitis C 95
Spin trapping of free radical products of CCl4 activation using pulse radioly¬sis and high energy radiation procdures. 94
Totale 11.469
Categoria #
all - tutte 127.589
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 127.589


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.908 0 82 442 179 65 32 221 44 118 41 296 388
2022/20233.968 316 134 212 179 291 381 77 189 1.988 17 112 72
2023/2024878 89 71 56 16 224 2 201 15 11 6 55 132
2024/20252.557 33 9 126 74 64 218 281 213 668 301 85 485
2025/20268.228 281 290 654 1.141 593 668 1.432 1.414 593 646 364 152
2026/2027793 297 496 0 0 0 0 0 0 0 0 0 0
Totale 24.239